Literature DB >> 33068001

Reversal of Age-Related Neuronal Atrophy by α5-GABAA Receptor Positive Allosteric Modulation.

Thomas D Prevot1, Akiko Sumitomo1, Toshifumi Tomoda1, Daniel E Knutson2, Guanguan Li2, Prithu Mondal2, Mounira Banasr1,3,4, James M Cook2, Etienne Sibille1,3,4.   

Abstract

Aging is associated with reduced brain volume, altered neural activity, and neuronal atrophy in cortical-like structures, comprising the frontal cortex and hippocampus, together contributing to cognitive impairments. Therapeutic efforts aimed at reversing these deficits have focused on excitatory or neurotrophic mechanisms, although recent findings show that reduced dendritic inhibition mediated by α5-subunit containing GABA-A receptors (α5-GABAA-Rs) occurs during aging and contributes to cognitive impairment. Here, we aimed to confirm the beneficial effect on working memory of augmenting α5-GABAA-R activity in old mice and tested its potential at reversing age-related neuronal atrophy. We show that GL-II-73, a novel ligand with positive allosteric modulatory activity at α5-GABAA-R (α5-PAM), increases dendritic branching complexity and spine numbers of cortical neurons in vitro. Using old mice, we confirm that α5-PAM reverses age-related working memory deficits and show that chronic treatment (3 months) significantly reverses age-related dendritic shrinkage and spine loss in frontal cortex and hippocampus. A subsequent 1-week treatment cessation (separate cohort) resulted in loss of efficacy on working memory but maintained morphological neurotrophic effects. Together, the results demonstrate the beneficial effect on working memory and neurotrophic efficacy of augmenting α5-GABAA-R function in old mice, suggesting symptomatic and disease-modifying potential in age-related brain disorders.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Entities:  

Keywords:  GABA; aging; cognition; neurotrophic effect; positive allosteric modulator

Mesh:

Substances:

Year:  2021        PMID: 33068001      PMCID: PMC7786363          DOI: 10.1093/cercor/bhaa310

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  85 in total

1.  Impaired recognition memory and decreased prefrontal cortex spine density in aged female rats.

Authors:  Maureen Wallace; Maya Frankfurt; Adolfo Arellanos; Tomoko Inagaki; Victoria Luine
Journal:  Ann N Y Acad Sci       Date:  2007-02       Impact factor: 5.691

2.  Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents.

Authors:  Sriparna Ghosal; Catharine H Duman; Rong-Jian Liu; Min Wu; Rosemarie Terwilliger; Matthew J Girgenti; Eric Wohleb; Manoela V Fogaca; Emily M Teichman; Brendan Hare; Ronald S Duman
Journal:  Neurobiol Dis       Date:  2019-11-07       Impact factor: 5.996

3.  Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease.

Authors:  Liana G Apostolova; Amity E Green; Sona Babakchanian; Kristy S Hwang; Yi-Yu Chou; Arthur W Toga; Paul M Thompson
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Jan-Mar       Impact factor: 2.703

4.  Glutamatergic regulation prevents hippocampal-dependent age-related cognitive decline through dendritic spine clustering.

Authors:  Ana C Pereira; Hilary K Lambert; Yael S Grossman; Dani Dumitriu; Rachel Waldman; Sophia K Jannetty; Katina Calakos; William G Janssen; Bruce S McEwen; John H Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

Review 5.  Somatostatin, Alzheimer's disease and cognition: an old story coming of age?

Authors:  Jacques Epelbaum; Jean-Louis Guillou; François Gastambide; Daniel Hoyer; Emmanuelle Duron; Cécile Viollet
Journal:  Prog Neurobiol       Date:  2009-07-10       Impact factor: 11.685

Review 6.  Beta-amyloid deposition and the aging brain.

Authors:  Karen M Rodrigue; Kristen M Kennedy; Denise C Park
Journal:  Neuropsychol Rev       Date:  2009-11-12       Impact factor: 7.444

Review 7.  Dendritic spine changes associated with normal aging.

Authors:  D L Dickstein; C M Weaver; J I Luebke; P R Hof
Journal:  Neuroscience       Date:  2012-10-13       Impact factor: 3.590

8.  Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology.

Authors:  R A Rissman; A J Mishizen-Eberz; T L Carter; B B Wolfe; A L De Blas; C P Miralles; M D Ikonomovic; D M Armstrong
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Problem solving, working memory, and motor correlates of association and commissural fiber bundles in normal aging: a quantitative fiber tracking study.

Authors:  Natalie M Zahr; Torsten Rohlfing; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Neuroimage       Date:  2008-10-14       Impact factor: 6.556

View more
  3 in total

1.  Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress.

Authors:  Ashley Bernardo; Philip Lee; Michael Marcotte; Md Yeunus Mian; Sepideh Rezvanian; Dishary Sharmin; Aleksandra Kovačević; Miroslav M Savić; James M Cook; Etienne Sibille; Thomas D Prevot
Journal:  Neuropsychopharmacology       Date:  2022-06-14       Impact factor: 8.294

2.  MD2 contributes to the pathogenesis of perioperative neurocognitive disorder via the regulation of α5GABAA receptors in aged mice.

Authors:  Wenqiang Zuo; Jianshuai Zhao; Jinming Zhang; Zongping Fang; Jiao Deng; Ze Fan; Yaru Guo; Jing Han; Wugang Hou; Hailong Dong; Feifei Xu; Lize Xiong
Journal:  J Neuroinflammation       Date:  2021-09-16       Impact factor: 8.322

3.  Positive Allosteric Modulation of α5-GABAA Receptors Reverses Stress-Induced Alterations in Dopamine System Function and Prepulse Inhibition of Startle.

Authors:  Alexandra M McCoy; Thomas D Prevot; Md Yenus Mian; James M Cook; Alan Frazer; Etienne L Sibille; Flavia R Carreno; Daniel J Lodge
Journal:  Int J Neuropsychopharmacol       Date:  2022-08-16       Impact factor: 5.678

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.